跳至主要内容
临床试验/NCT06658821
NCT06658821Enrolling By Invitation不适用

The Effect of LDL557 on Improving Degenerative Arthritis in the Elderly

Chung Shan Medical University2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年2月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
100
试验地点
2
主要终点
WOMAC

研究概览

简要总结

This project is to conduct a clinical trial of SYNBIO TECH INC.'s LDL557 capsule for joint protection. To understand the improvement of joint discomfort and inflammation after supplementation, we hope to provide an updated choice for modern people's joint protection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI 18-40 kg/m2;
  • Those with early stage degenerative arthritis symptoms judged by X-ray to be Kellgren-Lawrence Grading Scale level 1 or 2, and the physician determines that long-term treatment is not needed or WOMAC score>2.0 or WOMAC total scale score>12 or VAS score ≦6.

排除标准

  • alcoholism
  • breastfeeding women and pregnant women.
  • Those consuming dietary supplements were excluded.
  • Those who use non-steroidal anti-inflammatory analgesics and those who have had joint surgery.
  • Rheumatoid arthritis.
  • Those who have had joint injections within 6 months.
  • Those with cardiovascular and cerebrovascular, rheumatoid or mental diseases.
  • Patients undergoing cancer treatment.

研究组 & 干预措施

LDL557-HK capsule

Experimental

Subjects will take one capsule of the experimental group(LDL557-HK capsule) within 30 minutes before lunch during the experimental period.

干预措施: LDL557-HK capsule (Dietary Supplement)

Placebo capsule

Placebo Comparator

Subjects will take one placebo capsule within 30 minutes before lunch during the experimental period.

干预措施: Placebo Capsule (Dietary Supplement)

结局指标

主要结局

WOMAC

时间窗: Baseline, Week 4, Week 8, and Week 12

The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is widely used in the evaluation of Hip and Knee Osteoarthritis. Higher scores indicate worse pain, stiffness, and functional limitations. The WOMAC measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68).

次要结局

  • Inflammation assessment(Baseline and Week 12)
  • Thigh circumference(Baseline and Week 12)
  • KOOS(Baseline, Week 4, Week 8, and Week 12)
  • Lequesne's index(Baseline, Week 4, Week 8, and Week 12)
  • VAS(Baseline, Week 4, Week 8, and Week 12)
  • Quality of life (QOL) SF-36(Baseline, Week 4, Week 8, and Week 12)
  • Kellgren-Lawrence Grade(Baseline and Week 12)
  • Joint range of motion assessment(Baseline and Week 12)
  • Timed Up and Go Test(Baseline and Week 12)
  • Stair Climb Test(Baseline and Week 12)
  • Aerobic Capacity(Baseline and Week 12)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验